DISTRIBUTION OF ASTROCYTIC TUMORS AND BRAIN METASTASES BY ANATOMICAL LOCATION: A STUDY CONDUCTED ON 91 PATIENTS

Authors

  • G. C. MOROȘAN Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • Andreea-Cătălina MOROȘAN Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • R. DOBRIN Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • L. C. GAVRIL Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • A. CIOBICĂ “Alexandru “Ioan Cuza” University Iaşi, Romania
  • Anca SAVA Grigore T. Popa” University of Medicine and Pharmacy Iasi

Abstract

This retrospective study examines the distribution of astrocytic tumors and brain metastases based on anatomical location. Materials and methods: the study included a cohort of 91 patients treated at “Prof. Dr. N. Oblu” Emergency Clinical Hospital in Iasi, Romania, between 2011 and 2023. The study focuses on tumors localized in the frontal, parietal, and temporal lobes, with a particular emphasis on the association between these tumors and pre-diagnosis psychiatric symptoms. Results: Data were collected from pathology records, including patient demographics, tumor type, location, and histopathological characteristics. The analysis reveals a significant prevalence of astrocytic tumors in the frontal lobes for both male and female patients, with glioblastoma multiforme being the most common tumor type. The study also highlights the impact of tumor location on the presentation and progression of psychiatric symptoms, underscoring the need for tailored treatment approaches. Conclusions: These findings contribute to a better understanding of the relationship between tumor location, patient outcomes, and the potential for targeted therapeutic strategies.

Author Biographies

  • G. C. MOROȘAN, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Morpho-Functional Sciences (I)

  • Andreea-Cătălina MOROȘAN, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Medical Specialties (II)

  • R. DOBRIN, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Medical Specialties (II)

  • L. C. GAVRIL, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Morpho-Functional Sciences (I)

  • A. CIOBICĂ, “Alexandru “Ioan Cuza” University Iaşi, Romania

    Faculty of Biology / Department of Molecular and Experimental Biology
    Centre of Biomedical Research, Romanian Academy
    Academy of Romanian Scientists

  • Anca SAVA, Grigore T. Popa” University of Medicine and Pharmacy Iasi

    Faculty of Medicine
    Department of Morpho-Functional Sciences (I)

References

1. Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro-oncology 2019; 21(Suppl 5): v1-v100 / doi: 10.1093/neuonc/noz150.
2. Ostrom QT, Gittleman H, Xu J, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. Neuro-oncology 2016; 18(Suppl 5): v1-v75 / doi: 10.1093/neuonc/now207.
3. Smoll NR, Drummond, KJ. The incidence of medulloblastomas and primitive neuroectodermal tumors in adults and children. Journal of Clinical Neuroscience 2012; 19(11): 1541-1544 / doi: 10.1016/j.jocn.2012.04.009.
4. Ostrom QT, Gittleman H, Farah P, et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro-oncology, 2013; 15 (Suppl 2): ii1-ii56 / doi: 10.1093/neuonc/not151.
5. Arabestanino A, Ai A, Jalali H. A Histopathology Model of Astrocytoma: A Review. Systematic Reviews in Pharmacy 2022; 13(2) / doi: 10.31858/0975-8453.13.4.229-234.
6. Moore AJ. Brain tumors. Postgraduate Medicine, 1998; 84(2): 163-166 / doi: 10.1080/00325481. 1988.11700373.
7. Palmieri A, Valentinis L, Zanchin G. Update on headache and brain tumors. Cephalalgia 2020; 41(4): 431-437 / doi: 10.1177/0333102420974351.
8. Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 pa-tients. Neurology 1993; 43(9): 1678-1683 / doi: 10.1212/wnl.43.9.1678.
9. Schankin CJ, Ferrari U, Reinisch VM, Birnbaum T, Goldbrunner R, Straube A. Characteristics of brain tumour-associated headache. Cephalalgia: an international journal of headache 2007; 27(8): 904-911 / doi: 10.1111/j.1468-2982.2007.01368.x
10. Lowry JK, Snyder JJ, Lowry PW. Brain tumors in the elderly: recent trends in a Minnesota cohort study. Archives of neurology 1998; 55(7): 922-928 / doi: 10.1001/archneur.55.7.922
11. Sefi-Yurdakul N. Visual findings as primary manifestations in patients with intracranial tu-mors. International journal of ophthalmology 2015; (4): 800-803 / doi: 10.3980/j.issn.2222-3959. 2015.04.28.
12. Masayaanon P, Lorpattanakasem, J. Intracranial tumors affecting visual system: 5-year review in Prasat Neurological Institute. Journal of the Medical Association of Thailand Chotmaihet thangphaet 2008; 91(4): 515-519.
13. Wihl J, Rosell L, Frederiksen K, Kinhult S, Lindell G, Nilbert M. Contributions to Multidisciplinary Team Meetings in Cancer Care: Predictors of Complete Case Information and Comprehensive Case Discussions. Journal of multidisciplinary healthcare 2021; 14: 2445-2452 / doi: 10.2147/ JMDH.S309162.
14. Salari, N, Fatahian, R, Kazeminia, M, et al. Patients’ Survival with Astrocytoma After Treatment: A Systematic Review and Meta-analysis of Clinical Trial Studies. Indian journal of surgical oncolo-gy 2022; 13(2): 329-342 / doi: 10.1007/s13193-022-01533-7.
15. Brown PD, Buckner JC, O’Fallon JR, et al Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. International journal of radiation oncology, biology, physics 2004; 58(4): 1153-1160 / doi: 10.1016/j.ijrobp. 2003.09.020
16. Berzero G, Bellu L, Baldini C, et al. Sustained Tumor Control with MAPK Inhibition in BRAF V600-Mutant Adult Glial and Glioneuronal Tumors. Neurology 2021; 97(7): e673-e683 / doi: 10.1212/ WNL.0000000000012330.
17. Wen PY, Stein A, van den Bent MJ, De Greve J, et al. Dabrafenib plus trametinib in patients with BRAFV600E-mutant low-grade and high-grade glioma (ROAR): a multicenter, open-label, single-arm, phase 2, basket trial. The Lancet. Oncology 2022; 23(1): 53-64 / doi: 10.1016/ S1470-2045(21)00578-7.
18. Wick W, Roth, P, Hartmann, C, Hau, P, et al Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide. Neuro-oncology 2016; 18(11): 1529-1537 / doi: 10.1093/neuonc/now133.
19. van den Bent MJ, Tesileanu CMS, Wick W, et al. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomized, open-label, phase 3 study. The Lancet Oncology 2021; 22(6): 813-823 / doi: 10.1016 /S1470-2045 (21) 00 090-5.
20. Zigiotto, L, Annicchiarico, L, Corsini, F, et al Effects of supra-total resection in neurocognitive and oncological outcome of high-grade gliomas comparing asleep and awake surgery. Journal of neuro-oncology, 2020; 148(1), 97-108 / doi: 10.1007/s11060-020-03494-9.
21. Diffuse midline glioma: diagnosis and treatment. (2024, March 23rd). Cancer.gov. https://www.cancer.gov/rare-brain-spine-tumor/tumors/diffuse-midline-gliomas
22. Glantz, M, Cole, B, Forsyth, P, et al Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors (RETIRED). Neurology 2000; 54(10): 1886-1893 / doi: 10.1212/wnl. 54.10.1886
23. Fonkem E, Bricker P, Mungall D, et al. The role of levetiracetam in treatment of seizures in brain tumor patients. Frontiers in Neurology 2013; 4 / doi: 10.3389/fneur.2013.00153
24. Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treat-ment. Nature reviews. Neurology 2009; 5(4): 210-220 / doi: 10.1038/nrneurol.2009.24
25. Finocchiaro CY, Petruzzi A, Lamperti E, et al. The burden of brain tumor: a single-institution study on psychological patterns in caregivers. Journal of neuro-oncology 2012; 107(1): 175-181 / doi: 10.1007/s11060-011-0726-y
26. Madsen K, Poulsen HS. Needs for everyday life support for brain tumor patients’ relatives: systematic literature review. European journal of cancer care 2011; 20(1): 33-43 / doi: 10.1111 /j.1365-2354. 2010.01184.x
27. Chambers SK, Grassi L, Hyde MK, Holland J, Dunn J. Integrating psychosocial care into neuro-oncology: challenges and strategies. Frontiers in oncology 2015; 5: 41 / doi: 10.3389/ fonc. 2015. 00041.

Additional Files

Published

2024-09-18

Issue

Vol. 128 No. 3 (2024): The Medical-Surgical Journal

Section

BASIC SCIENCES

License

COPYRIGHT 
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.

COPYRIGHT TRANSFER FORM FOR 

REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /

THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI

We, the undersigned authors of the manuscript entitled

_____________________________________________________________________________________

_____________________________________________________________________________________

warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.

  1. we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
  2. the manuscript does not break the intellectual property rights of any other person.
  3. we have read the submitted version of the manuscript and we are fully responsible for the content.

Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):

  1. ______________________________/_________________________
  2. ______________________________/_________________________
  3. ______________________________/_________________________

N.B.  All the authors must sign this form